Futurestudies should incorporate Treg-specific markers such as FOXP3 tofurther characterize the functional phenotype of CD25+ Tcells and confirm the suitability of Diatom-aAPCs for pro-inflammatoryapplications such as cancer immunotherapy. This evidence concerns the gene FOXP3 and cancer.